Cancer

Combining another drug with platinum-based chemotherapies may be more effective against ovarian cancer. Read More

Archived tissue samples are yielding new disease biomarkers. Read More

Eric Delpire, Ph.D., professor of Anesthesiology, Molecular Physiology and Biophysics and director of the Anesthesiology Basic Science Research Division, has spent the past 15 years developing genetically altered mice for use in scientific research, and he now knows the value of his research in a very personal way. Read More

The machinery that builds the characteristic shape of epithelial cells suppresses breast cancer formation and metastasis in a mouse model. Read More

Researchers have determined how a DNA lesion caused by exposure to chemicals may spark cancer formation. Read More

Disney television personality Coco Jones will be the featured performer at this year’s Dunkin’ Donuts/Baskin-Robbins Family Day in Nashville. The annual T.J. Martell Foundation event, which raises funds in support of cancer research at institutions like Vanderbilt-Ingram Cancer Center, will be held Sunday, Nov. 11, from 1 to 4 p.m. at the Curb Event Center, Belmont University. Read More

Green tea may lower risk of some digestive cancers. Read More

New space on the 10th floor of the Critical Care Tower is allowing the myelosuppression unit to increase its number of available beds. (Photo by Susan Urmy) The 10th floor of Vanderbilt University Medical Center’s Critical Care Tower, housing a new myelosuppression unit, will open Oct. 27. Read More

Vanderbilt investigators have identified how two key components of cancer's invasive "switch" — the series of signaling events that turn on a tumor cell’s invasive behavior — work together. Read More

New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified. Read More

A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies. Read More

(photo by Joe Howell) LaManda Watson, left, receives a Team Vanderbilt T-shirt from Elizabeth Wilson for participating in the Fall Cancer Walks signup event held recently.  Vanderbilt-Ingram Cancer Center is sponsoring at least eight cancer walks this fall. For more information and to register online, visit www.viccfallwalks.org. Read More

Patrick Grohar, M.D., Ph.D., was awarded a $250,000 Hyundai Hope on Wheels grant last week for his research into potential drug therapies for Ewing sarcoma, a cancer of the bone. Read More

Racial differences exist in quality surgical care, new research from VICC finds. Read More

A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows. Read More

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments. Read More

Investigators from Vanderbilt-Ingram Cancer Center and three other cancer centers have identified a link between a rare genetic variant and the risk of developing glioma. Read More

Maryville, Tenn., tucked in the foothills of the Great Smoky Mountains, has a population of just 27,000, but it seemed like every one of its residents rallied around 20-year-old Brently Mancini when he was diagnosed with a rare soft tissue cancer. Read More

Carlos Arteaga, M.D., associate director for Clinical Research and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been named to the Scientific Advisory Board of the Susan G. Komen for the Cure Breast Cancer Research Foundation. Read More

An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to a specific drug therapy, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation. Read More